BPC-157 FDA Approval Status: The Short Answer Here's the bottom line: BPC-157 isn't FDA-approved for any indication
10.4291/wjgp.v11.i1.1 40 GrgicT.GrgicD.DrmicD.SeverA
Recalls & Warnings April 26, 2013 Seller of Immune, Cholesterol, Liver and Blood Sugar Products Warned For Drug Claims On March 20, 2013, the FDA issued a warning letter to Birkdale Medicinals LLC, following a review of the company's website which found statements made about Birkdale products, including Immune Response 247, Cholestat, Silymarin 81 and LevelStat, to be drug claims
A review of top-ranking med spa websites reveals a consistent set of marketing claims for B12 injections: increased energy, improved mental clarity, enhanced metabolism, support for weight loss, better skin health, and even anti-aging benefits
These studies suggest that the loss of antioxidant defense is an early biochemical event rather than a late-stage consequence of neuronal death
The most common sites for B12 injections are the deltoid (upper arm), vastus lateralis (outer thigh), ventrogluteal (hip), abdomen, and outer upper arm for subcutaneous injections